Lexcura Clinical Insights

Episode three of the diagnostic delay series is sepsis, the condition Michelle Carroll calls the clearest example in medicine of a diagnosis that is visible in the chart before the clinicians see it.
She explains in plain terms what sepsis is, why the treatment is simple but the timing is everything, and how hospitals are measured on a three-hour bundle that starts at “time zero,” the moment sepsis is recognized. That moment is the whole case. A hospital that sets time zero at the first physician note mentioning sepsis can look compliant on paper while the heart rate, temperature, and respiratory rate had been climbing for six hours.
The episode walks the seven pillars through a sepsis record: plotting every vital sign and organ-function lab on one timeline, checking vital sign frequency and entry times under Record Integrity, accounting for beta blockers and elderly patients who never mount a fever under Baseline, and identifying every escalation point where a nurse didn’t call, a physician didn’t come, or the response was “recheck in two hours.” She also covers the automated sepsis alerts most electronic records fire, and why a dismissed alert in the audit trail is very hard to explain away.
A composite case follows a nursing home resident with a chronic catheter from the first quiet change in condition on a Monday to septic shock on a Thursday, and shows why the attorney almost missed the case by requesting only the hospital chart.
The episode closes with the defense’s two main moves, the time-zero argument and the frailty argument, a note on when the infection itself was preventable, and a checklist of what to request, from the sepsis screening tool to the gap between antibiotic order time and administration time.
Episode 84 moves to cancer, where the clock runs in months and the missed finding is usually sitting in a report nobody followed up on.
Lexcura Clinical Insights is hosted by Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit. Medical-Legal Analysis for attorneys. lexcurasummit.com

Episode two of the diagnostic delay series takes on stroke, the clearest example in medicine of a condition where the clock is the treatment.
Michelle Carroll starts with last known well, the single most important time in a stroke chart and one that is frequently never documented. She explains how the treatment window is built around it, why triage notes like “found with slurred speech” don’t establish it, and how Lexcura reconstructs it from the EMS run sheet, the 911 log, and the family’s account before holding the hospital record against it.
From there she walks the seven pillars through a stroke case: stroke scale documentation and entry timestamps under Record Integrity, prior deficits under Baseline, and the most common error in missed-stroke cases under Imaging Analysis, where a normal head CT is treated as ruling out a stroke it cannot see. She covers door-to-CT and door-to-drug benchmarks, stroke center certification, and the two classic misattributions: symptoms labeled as intoxication or migraine without a neuro exam, and younger patients dismissed because stroke is still treated as an older person’s disease.
A composite case follows a man in his forties through seven hours in an emergency department before a stroke alert fires. The episode closes with the defense arguments specific to stroke, including the treatment window, exclusion criteria, stroke scale scores, and thrombectomy availability, and a spoken checklist of what to request in discovery, from the prehospital stroke screen to the telestroke consultation log.
Episode 83 turns to sepsis, where the signal is quiet, spread across hours of vital signs, and the clock starts before anyone says the word.
Lexcura Clinical Insights is hosted by Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit. Medical-Legal Analysis for attorneys. lexcurasummit.com

This episode opens a five-part series on diagnostic delay and missed diagnosis, the single most common pattern in the cases Lexcura Summit reviews.
Michelle Carroll explains the difference between a missed diagnosis and a delayed one, and why delay cases are so easy to misjudge at intake: the chart says stroke, or sepsis, and everything after that line reads like competent medicine. The problem lives in the hours or days before it.
She walks through how the seven pillars of the Lexcura Clinical Intelligence Model apply to delay, from Record Integrity through Causation Mapping, and introduces the pattern that repeats across nearly every delay case: an early signal in the flowsheet, a missed escalation, a stretch of quiet charting, and then the event. A composite case from a post-surgical admission shows what that pattern looks like laid out on a single timeline, where twenty-nine hours passed between the first abnormal vital sign and the first intervention.
Episodes 82 through 85 take stroke, sepsis, cancer, and the discharged chest pain patient one at a time.
Lexcura Clinical Insights is hosted by Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit. Medical-Legal Analysis for attorneys. lexcurasummit.com

When a family chooses hospice, they’re giving up curative treatment in exchange for one promise: comfort. In part four of our end-of-life series, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, looks at what happens when that promise breaks down.
Hospice is under more federal scrutiny than ever. CMS has put a nationwide freeze on new hospice enrollments, suspended payments to hundreds of agencies, and put six states under heightened oversight. Michelle explains how fraud and poor care tend to show up together. She walks through the federal rules that set the standard of care: assessment deadlines, plan-of-care updates, aide supervision, round-the-clock nursing, and the patient’s right to effective pain control.
Using a fictional case of a man who died in pain at home after missed visits and a morphine supply that ran out, she shows how to rebuild what actually happened. That means using visit timestamps, after-hours call logs, answering service records, pharmacy deliveries, HOPE assessments, and what the family kept themselves. She also covers live discharge, improper enrollment of patients who weren’t dying, who’s responsible when hospice care happens in a nursing home, and why suffering at the end of life is real harm.
This episode is for attorneys reviewing hospice cases and anyone who wants to understand what good end-of-life care should look like.

A patient can do everything right. She signs a living will, completes a POLST form with her doctor and chooses no CPR. Then a hospital stay, a missing transfer packet and a default order change her record to “full code.” When she’s found unresponsive, the nurse follows what the record says.
In this second episode of the end-of-life series on Lexcura Clinical Insights, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, explains the documents people mix up all the time: advance directives, health care proxies, DNR orders and POLST forms. She covers what each one does and why only some of them are orders a nurse or paramedic can act on. She also walks through the federal rules requiring facilities to ask about advance directives, and the Supreme Court case that recognized the right to refuse treatment.
Using a fictional case, Michelle shows where these decisions usually break down: at admissions, readmissions and transfers. She also explains why courts have struggled with claims over being resuscitated against your wishes, and what recent settlements and nursing board discipline tell us. And she covers the opposite mistake, when a DNR is treated as “don’t treat” rather than “don’t start CPR.”
For attorneys, she lists the records that decide these cases and the questions to ask of each one.
This episode is educational and isn’t legal or medical advice.
Next in the series: what happens when the patient can’t speak for themselves and the family can’t agree.

A patient can do everything right. She signs a living will, completes a POLST form with her doctor and chooses no CPR. Then a hospital stay, a missing transfer packet and a default order change her record to “full code.” When she’s found unresponsive, the nurse follows what the record says.
In this second episode of the end-of-life series on Lexcura Clinical Insights, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, explains the documents people mix up all the time: advance directives, health care proxies, DNR orders and POLST forms. She covers what each one does and why only some of them are orders a nurse or paramedic can act on. She also walks through the federal rules requiring facilities to ask about advance directives, and the Supreme Court case that recognized the right to refuse treatment.
Using a fictional case, Michelle shows where these decisions usually break down: at admissions, readmissions and transfers. She also explains why courts have struggled with claims over being resuscitated against your wishes, and what recent settlements and nursing board discipline tell us. And she covers the opposite mistake, when a DNR is treated as “don’t treat” rather than “don’t start CPR.”
For attorneys, she lists the records that decide these cases and the questions to ask of each one.
This episode is educational and isn’t legal or medical advice.

This year brought the biggest expansion of medical aid in dying since Oregon passed the first law in the 1990s. Delaware’s law took effect in January, New York’s in August, and Illinois’s in September. That brings the total to fourteen U.S. jurisdictions.
In this episode of Lexcura Clinical Insights, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, walks through what these laws actually allow and what they don’t. She covers who qualifies, why the request has to come from the patient and not a family member or an advance directive, and why the patient has to take the medication themselves. Euthanasia remains illegal everywhere in the United States. She also explains how waiting periods and residency rules differ from state to state. And she clears up a common mix-up: refusing treatment, comfort care and palliative sedation are legal everywhere, and none of them is aid in dying.
Michelle also covers the latest news:
Canada: the government decided on October 7 to indefinitely keep people whose only condition is a mental illness out of MAID.
United Kingdom: the assisted dying bill for England and Wales stalled in the House of Lords and will be reintroduced. Scotland rejected its bill, and Jersey approved one.
New York: a disability-rights challenge to the law was dismissed, and religious groups filed their own challenge.
For attorneys, Michelle explains where disputes are likely to arise and which records will decide them.
This episode is educational and isn’t legal or medical advice. If you’re struggling or thinking about ending your life, please reach out. In the U.S., call or text 988, any time.

On September 8, 2026, HHS announced $383.4 million in grants through SAMHSA to strengthen behavioral health treatment, prevention, and crisis response. About $252 million goes to the 988 Suicide and Crisis Lifeline, suicide prevention, and mobile crisis services. The rest goes to substance use treatment and prevention, child traumatic stress programs, rural EMS training, and programs that bring primary care and behavioral health together.
In this episode of Lexcura Clinical Insights, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, explains why a call to 988 is only the beginning, and why local capacity and follow-up matter as much as the line itself. She then covers the legal side: grant compliance and False Claims Act exposure, the developing standard of care for crisis response, and documentation and handoffs. She also addresses confidentiality under HIPAA and the federal Part 2 rule for substance use records, EMTALA obligations for psychiatric emergencies, and the legal questions raised by sending fewer police to mental health calls. She closes with a checklist for reviewing the record in behavioral health crisis cases.
Learn more at lexcurasummit.com.

In September 2026, CMS placed eleven durable medical equipment suppliers on its Preclusion List, cutting off their Medicare Advantage and Part D payments. The suppliers were tied to more than $3.4 billion in suspected fraudulent billing in 2025 and 2026. Every one of them billed for patients who had already died. Many had no claims history before 2025, and four had already been removed from traditional Medicare before moving to Medicare Advantage plans.
In this episode of Lexcura Clinical Insights, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, walks through the cases CMS described. One supplier submitted $18.4 million in catheter claims over two days, and another billed for orthotics that patients said they never ordered. She explains what the Preclusion List does and doesn't mean, and the clinical red flags that show up when the medical record and the billing record don't match. She also covers the legal issues for whistleblowers, health plans, clinicians whose identities were misused, and patients whose records were corrupted by fraudulent claims.
Learn more at lexcurasummit.com.

In January 2026, the CDC approved a revised childhood immunization schedule without the usual vote by its expert advisory committee. Recommendations for hepatitis A, meningococcal ACWY, RSV, rotavirus, and influenza moved away from routine vaccination for all children, and the HPV series was reduced to a single dose. The American Academy of Pediatrics and other groups sued. In March 2026, a federal court in Massachusetts stayed the new schedule and the appointments of thirteen advisory committee members, and the government appealed.
In this episode of Lexcura Clinical Insights, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, explains what changed and why. She sets out the administration's reasons and the medical community's objections side by side. Then she turns to the legal questions: how competing national schedules complicate the standard of care, why documenting shared clinical decision-making matters more than ever, and whether these vaccines still qualify for the National Vaccine Injury Compensation Program. She also covers insurance coverage, school requirements that now differ from state to state, and what attorneys should look for in the medical record.
Learn more at lexcurasummit.com.